A Non Interventional Study to Monitor the Safety and Effectiveness of Trajenta (Linagliptin, 5 mg, q.d) in Korean Patients With Type 2 Diabetes Mellitus
Clinical trial NCT01707147 · COMPLETED
Trial details
- NCT number
- NCT01707147
- Sponsor
- Boehringer Ingelheim
- Status
- COMPLETED
- Study type
- OBSERVATIONAL
- Start date
- 2012-11-16
- Primary completion
- 2017-07-11
- Enrollment
- 3219
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.